版本:
中国

BRIEF-ARCA Biopharma Q1 loss per share $0.48

May 15 Arca Biopharma Inc

* Arca biopharma announces first quarter 2017 financial results and provides business update

* Q1 loss per share $0.48

* Arca biopharma - current cash, cash equivalents and marketable securities will be sufficient to fund operations, at its projected cost structure, through end of 2017

* Arca biopharma inc - cash, cash equivalents and marketable securities totaled $19.2 million as of march 31, 2017, compared to $23.5 million as of december 31, 2016

* Arca biopharma-expects g&a expenses in 2017 to be higher than in 2016 as it increases administrative activities to support genetic-af clinical trial Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐